Of note, the treatment of pneumococcal pneumonia with the Annexin A1 peptide Ac2-26, a pro-resolving mediator, did not increase IL-10, while reducing the inflammatory response, lung damage, bacterial loads and increasing phagocytosis [11]. Here, ANXA1 is linked to pneumococcal pneumonia.